Literature DB >> 35983772

Monkeypox self-diagnosis abilities, determinants of vaccination and self-isolation intention after diagnosis among MSM, the Netherlands, July 2022.

Haoyi Wang1, Kennedy J I d'Abreu de Paulo1, Thomas Gültzow1, Hanne M L Zimmermann1, Kai J Jonas1.   

Abstract

Monkeypox is a zoonotic disease and leads to a smallpox-like disease in humans. The current epidemic in European countries requires informed responses. We investigated the ability to self-diagnose a potential infection, and determinants of vaccination and self-isolation intention after diagnosis among 394 MSM in the Netherlands. We found that about half were able to self-diagnose monkeypox, that 70% had a high intention to get vaccinated and 44% to self-isolate after monkeypox diagnosis. Determinants went beyond mere risk behaviour criteria.

Entities:  

Keywords:  Isolation; MSM; Monkeypox; Prevention; Self-diagnosis; Vaccination

Mesh:

Year:  2022        PMID: 35983772      PMCID: PMC9389856          DOI: 10.2807/1560-7917.ES.2022.27.33.2200603

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


The global epidemic of monkeypox, a zoonotic disease, has recently changed from infections predominantly following an interaction with animals, to human-to-human transmission [1,2]. The monkeypox epidemic in European countries is currently predominantly affecting men-who-have-sex-with-men (MSM) and the number of infections is still increasing [3,4]. In the Netherlands 1,025 cases have been reported as at 11 August 2022, the majority in Amsterdam. Given the spread of the disease, investigating self-diagnostic abilities, and vaccination and self-isolation intentions is relevant to tailor further public health responses.

Survey and participants

We conducted an online survey among MSM using a cohort established in 2017 [5] (n = 257), along with recruitment of MSM on a gay online dating app (n = 137) in the first half of July 2022, before the start of targeted monkeypox vaccination in the Netherlands [6]. Of the included 394 MSM, 43% (n=171) were below the age of 45-years, 6% (n=22) were living with HIV and 66% (n=241) were currently using HIV pre-exposure prophylaxis (PrEP) (see supplementary materials S1 for the population characteristics by PrEP use status, and S2 for participants’ age distribution).

Monkeypox self-diagnosis

We provided participants with four images and asked them to indicate what condition this could be. All of the images were showing lesions in parts of the face, one depicted a monkeypox lesion, the other three a vesicle due to a staphylococcal skin infection, a syphilis stage-2, and eczema. Only the image of eczema was diagnosed predominantly correct (67%), monkeypox lesion and staphylococcal infection images triggered some correct hits, but also considerable amounts of false self-diagnoses (up to 48% and 58%, respectively, for all alternative diagnoses combined), syphilis stage-2 was most frequently misdiagnosed as monkeypox (52%) (Table 1).
Table 1

Ability to self-diagnose a monkeypox lesion among MSM, the Netherlands July 2022 (n=394)

Displayed on imageSelf-diagnosis
MonkeypoxStaphylococcusSyphilisEczema
n%n%n%n%
Monkeypox 20652.315038.1307.682.0
Staphylococcal skin infection 9423.916742.410526.6287.1
Syphilis stage-2 20451.89123.19123.182.0
Eczema 143.69824.9205.126266.5

Vaccination and self-isolation intentions

Vaccination intention and self-isolation intention were measured on a 1─5 Likert scale (with 1=“Very low” and 5=“Very high”). In this study, we categorised these two endpoints as “High/very high (scale 4 and 5)” and “The rest of the scale” for the modelling analysis. Overall, 70% of participants showed high vaccination intention and 44% showed high intention for self-isolation after diagnosis i.e. until all lesions are gone, usually for up to 21 days [7]. Given that currently monkeypox vaccinations are administered to PrEP-using MSM in the Netherlands [8], we adjusted for PrEP use status (current users (n = 241) vs PrEP-naïve MSM or PrEP-discontinued MSM (n = 122)) to compare the standardised prevalence ratio (SPR). We found that despite of the higher prevalence among PrEP users in both vaccination intention and self-isolation intention, the adjusted SPRs showed no significant differences, indicating similar vaccination and self-isolation intentions among PrEP users and non-PrEP-users (Table 2).
Table 2

Prevalence and standardised prevalence ratio of monkeypox vaccination and self-isolation intention, the Netherlands, July 2022 (n=394)

Sub-populationVaccination intention(Extremely likely vs rest of scale)a Monkeypox self-isolation intention(Extremely likely vs rest of scale)a
Prevalence95%CISPRb 95%CIPrevalence95%CISPRb 95%CI
n%n%
PrEP users 17873.8667.97–79.001.010.87–1.1710543.5737.45–49.811.060.87–1.28
Non-PrEP users 8771.3162.73–78.590.970.78–1.194335.2527.34–33.060.860.63–1.14
Total sample 27670.0165.35–74.36NANA17343.9139.09–48.84NANA

CI: confidence interval; NA: not applicable; PrEP: pre-exposure prophylaxis; SPR: standardised prevalence ratio.

a 1−5 Likert scale, with 1 = extremely unlikely and 5 = extremely likely)

b Adjusted for PrEP use status.

CI: confidence interval; NA: not applicable; PrEP: pre-exposure prophylaxis; SPR: standardised prevalence ratio. a 1−5 Likert scale, with 1 = extremely unlikely and 5 = extremely likely) b Adjusted for PrEP use status.

Determinants predicting vaccination and self-isolation intention

To identify vaccination intention differences and among MSM sub-populations and which sub-population may follow the current self-isolation policy best, we conducted two multivariable logistic regression analyses with socio-demographic, behavioural, and psychosocial determinants. First, we conducted univariable logistic modelling with each of the selected determinants to investigate potential correlations with being extremely likely to get vaccinated. We retained all determinants with p < 0.10 in the univariable analysis with the full variance in the multivariable model, given the relatively small sample size (Table 3) (supplementary materials S3 shows the analysis for collinearity). In a sensitivity analysis, we combined somewhat- and extremely-likely intentions to define high intention to explore the implications on the endpoint selection (sensitivity analysis results are shown in the supplementary materials S4).
Table 3

Determinants of monkeypox vaccination intention and self-isolation intention, the Netherlands, July 2022 (n=394)

VariablesVaccination intention (extremely likely vs rest of scale)Self-isolation intention (extremely likely vs rest of scale)
Univariable modelMultivariable modelUnivariable modelMultivariable model
OR95%CIp valueaOR95%CIp valueOR95%CIp valueaOR95%CIp value
Socio-demographic determinants
Age
< 45 yearsRef.NARef.Ref.
> 45 years1.040.67─1.610.8611.410.94─2.110.0981.110.70─1.770.663
Relationship
SingleRef.Ref.Ref.Ref.
Single but dating1.981.06─3.730.0332.421.13─5.200.0241.840.99─3.410.0521.570.82─3.030.177
Monogamous relationship0.790.36─1.750.5641.250.45─3.510.6710.790.34─1.850.5860.700.28─1.720.434
Open/polyamorous relationship3.441.94─6.08< 0.0013.961.97─7.990.0011.440.84─2.470.1861.200.67─2.170.536
Education
Lower than bachelorRef.NARef.Ref.
Bachelor0.940.53─1.670.8320.510.30─0.890.0170.540.30─0.950.034
Master1.170.66─2.080.5930.490.29─0.840.0090.520.29─0.930.029
PhD or higher1.910.71─5.180.2020.730.32─1.660.4540.830.34─2.560.676
Employment
EmployedRef.Ref.Ref.Ref.
Unemployed or receiving social welfare0.840.53─1.670.7330.990.29─3.480.9912.010.75─5.420.1661.770.63─4.930.274
Retired9.580.66─2.080.02811.041.35─90.360.0254.791.73─13.300.0035.351.84─15.570.002
Student1.060.71─5.180.8991.320.44─3.990.6130.760.30─1.950.5660.940.34─2.560.901
Migration status
Not applicableRef.NARef.Ref.
First-generation migrant0.830.44─1.550.5521.740.96─3.140.0691.820.97─3.450.064
Second-generation migrant0.900.31─2.690.8632.380.84─6.690.1012.590.84─8.000.098
Residence
The rest of the countryRef.NARef.NA
Randstad (main urban area)1.340.87─2.080.1860.790.53─1.190.263
Behavioural determinants
Number of sex partners in the previous 6 months
NoneRef.Ref.Ref.NA
12.360.50─11.120.2751.700.23─12.630.6030.710.15─3.350.669
2─63.330.76─14.480.1081.620.24─10990.6170.450.10─1.940.283
7─155.211.16─23.420.0312.260.32─16.250.4150.350.08─1.590.176
More than 156.371.38─29.360.0182.020.26─15.390.4990.520.12─2.310.389
HIV status
HIV-negativeRef.NARef.NA
HIV-positive1.110.42─2.930.8261.310.55─3.100.536
HIV status unknown or not disclosed0.330.08─1.270.1071.640.43─6.210.466
PrEP use status
Current PrEP userRef.Ref.Ref.NA
PrEP naïve or PrEP discontinued0.660.41─1.060.08720.780.41─1.490.4470.790.50─1.220.286
Any type of substance use in the previous 6 months
NeverRef.NARef.NA
Ever0.600.32─1.140.1211.390.74─2.580.302
Recreational drugs use in the previous 6 months a
NeverRef.NARef.NA
Ever 1.39 0.88─2.190.163 0.95 0.63─1.430.7957
Chemsex in the previous 6 months b
NeverRef.NARef.NA
Ever0.900.55─1.460.6590.880.56─1.390.585
Poppers use in the previous 6 months
NeverRef.NARef.NA
Ever1.350.88─2.080.1731.100.73─1.640.632
Erectile dysfunction medication use in the previous 6 months c
NeverRef.Ref.Ref.NA
Ever1.480.95─2.300.0870.770.43─1.390.3801.350.90─2.020.144
Alcohol use in the previous 6 months
NeverRef.NARef.NA
Ever1.080.65─1.770.7660.790.49─1.260.320
Visited a gay sauna in the previous 6 months
NeverRef.NARef.NA
Ever1.440.91─2.280.1191,010.66─1520.965
Visited a darkroom in the previous 6 months
NeverRef.NARef.NA
Ever1.340.86─2.100.1991.320.88─1.980.178
Visited a circuit party in the previous 6 months
NeverRef.NARef.NA
Ever1.010.63─1.640.9521.240.80─1.930.337
Visited a pride event in the previous 6 months
NeverRef.NARef.NA
Ever1.170.76─1.800.4811.010.68─1.500.978
Visited a gay dance club in the previous 6 months
NeverRef.NARef.NA
Ever1.050.67─1.650.8231.050.69─1.600.806
Attended private sex parties in the previous 6 months
NeverRef.NARef.NA
Ever1.200.74─1.930.4641.200.77─1.850.421
Visited fetish events/fairs in the previous 6 months
NeverRef.NARef.NA
Ever1.060.62─1.780.8401.210.75─1.960.427
Psychosocial determinants
Knowing anybody who has/had monkeypox
NoRef.Ref.Ref.NA
Yes2.871.41─5.840.0032.330.98─5.520.0551.170.69─1.970.565
Concern about being infected by monkeypoxd 1.741.40─2.16< 0.0011.741.35─2.26< 0.0011.100.94─1.300.236
Perceived risk of being infected by monkeypoxd 1.731.40─2.13< 0.0011.210.88─1.640.2371.130.94─1.360.190
Perceived problematic consequences of monkeypoxd 1.210.98─1.500.0751.180.90─1.530.2241.351.09─1.660.0051.391.11─1.740.005

aOR: adjusted odds ratio; CI: confidence interval; GHB: gamma-hydroxybutyric acid; MDMA: 3,4-methylenedioxymethamphetamine; NA: not applicable; OR: odds ratio; PrEP: pre-exposure prophylaxis; THC: tetrahydrocannabinol.

a I use substances recreationally (for example THC, MDMA, ecstasy, etc).

b I use substances in the context of sex (for example crystal methamphetamine/tina, GHB, ketamine etc.).

c I use erectile dysfunction medication (for example Viagra, Kamagra).

d indicates variable with a 1−5 Likert scale, with 1 = extremely unlikely and 5 = extremely likely)

aOR: adjusted odds ratio; CI: confidence interval; GHB: gamma-hydroxybutyric acid; MDMA: 3,4-methylenedioxymethamphetamine; NA: not applicable; OR: odds ratio; PrEP: pre-exposure prophylaxis; THC: tetrahydrocannabinol. a I use substances recreationally (for example THC, MDMA, ecstasy, etc). b I use substances in the context of sex (for example crystal methamphetamine/tina, GHB, ketamine etc.). c I use erectile dysfunction medication (for example Viagra, Kamagra). d indicates variable with a 1−5 Likert scale, with 1 = extremely unlikely and 5 = extremely likely) For vaccination intention as endpoint, among socio-demographic determinants, MSM who were single but dating (adjusted OR (aOR) = 2.42), who had an open/polyamorous relationship (aOR = 3.96) and who were retired (aOR = 11.04) were more likely to have high vaccination intentions. No behavioural determinants were found to be statistically associated. Among psycho-social determinants, we found that knowing someone who has/had monkeypox (aOR = 2.33) and being worried about a monkeypox infection (aOR = 1.74) was associated with high vaccination intention. For self-isolation intention as endpoint, almost all included socio-demographic determinants showed relevant associations. MSM with bachelor (aOR = 0.54) and master (aOR = 0.52) degrees were less likely to self-isolate after diagnosis for 21 days. Those who were retired (aOR = 5.35) showed higher intentions on the other hand. Similar to the vaccination intention, no behavioural determinant was found to be associated with high self-isolation intentions. Among psychosocial determinants, MSM who perceived more problematic consequences because of a monkeypox infection (aOR = 1.39) were more likely to self-isolate.

Discussion

Given the incubation period of 9 days in the case of exposure via mucous membranes (e.g., anus, mouth, urethra) [9], it is important to detect monkeypox infections quickly to limit onward transmission, which highlights the importance of affected individuals’ ability to detect the typical lesions early on. The findings from a survey including 394 MSM in the Netherlands showed that only about half of them were able to self-diagnose monkeypox from other skin lesions which shows that self-diagnosis in particular of novel diseases, can be challenging. Furthermore, infected individuals should isolate for up to 21 days until all symptoms are gone [4]. Especially after all coronavirus disease (COVID-19)-related quarantine measures, there are limited data available on the acceptance of such measures for other diseases, such as monkeypox. Our results showed that only 44% intended to fully self-isolate after receiving a monkeypox diagnosis. At the same time, vaccination programs have commenced in many countries that focus on high-risk populations, for example MSM who are using PrEP [8]. Our results revealed that 70% belonging to this group had a high intention to get vaccinated. Given vaccine scarcity [10], it is paramount to identify the populations with the highest risk, but also to gauge general vaccination intention in moderate at-risk populations. Our main findings hold relevant implications to guide national response to the monkeypox outbreak. Firstly, both the ability to self-diagnose and intention to self-isolate were relatively low among our study participants. Public health and social measures are considered essential [11] to reduce transmission of pathogens with epidemic potential. Thus, health education campaigns/interventions should not only aim to increase vaccination intentions, but also to support concerned individuals in following other mitigation measures such as isolation. Secondly, although close contact during sexual activities is the most frequently suspected route of infection [12] and the main reason to prioritise MSM using PrEP for vaccination in the Netherlands since 25 July 2022 [6], high intention to get vaccinated and self-isolate in this study were not predicted by any of the sexual risk behaviours. This is of note, as the current public communication and vaccination strategy in the Netherlands focuses on motivating those showing higher sexual risk behaviours, while in our study socio-demographic (e.g., education level and migration status) and psycho-social variables (e.g., “knowing someone that has/had monkeypox” and “higher concern about getting infected by monkeypox”) were found predictive for a higher vaccination and self-isolation intention. Our results could inform campaign content and dissemination planning of respective monkeypox prevention campaigns. They suggest it is crucial to increase our efforts to also reach highly educated with these messages, as well as to present realistic stories of monkeypox infections using peer-communication without inducing fear. Even though our findings and other research imply that under certain conditions having fear could increase intention to vaccinate and self-isolate [13]. Also, since vaccination intentions did not differ between PrEP users and non-PrEP-users and non-PrEP-users may also have risk behaviours, prioritising PrEP users may not be sufficient to reach the full potential of the vaccination. Finally, albeit most Dutch monkeypox cases have been reported from Amsterdam, our analysis of geographic differences did not yield significant results. However, our study is not devoid of limitations. As our analyses were conducted based on MSM from an existing cohort which aimed to investigate PrEP use [9] and MSM who were on an online gay dating app, both groups of participants may be more familiar with new media and rapid access to information sources, and thus may be more likely to have more knowledge about the monkeypox epidemic compared with the general MSM population living in the Netherlands. This may result in overestimated parameters. Additionally, PrEP use may be overrepresented among our participants compared with the general MSM population given the sampling strategy and hence our results may be limited to this population. Yet at the same time, PrEP users are the target group for monkeypox vaccinations in the Netherlands at the moment. Thus, we believe that our sample is capturing relevant parts of the at-risk population. Furthermore, we assessed the concern of getting a monkeypox infection, but did not investigate its determinants further. We believe that future research should investigate preventions intentions, for example, those that reflect changes in vaccine availability, and complement the emerging picture on attitudes related to monkeypox, such as determinants of infection concerns, and also triangulate results obtained among MSM with healthcare provider perspectives. Data from other contexts, for example Italy, show that healthcare providers currently lack relevant knowledge, underestimate the epidemic and the need for tailored responses [14].

Conclusions

To conclude, based on our findings public health policy makers and services should in addition to focussing on vaccinations in their communication, aim to increase MSM’s intentions to self-isolate and their ability to accurately self-diagnose. Efforts should also be stepped up to target MSM at the highest risk, especially those with little concern about monkeypox and those with a high level of education. Even though obtained in a Dutch context, we believe our findings may also be relevant for other countries with similar conditions.
  8 in total

1.  Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review.

Authors:  Nicola L Bragazzi; Jude D Kong; Naim Mahroum; Christina Tsigalou; Rola Khamisy-Farah; Manlio Converti; Jianhong Wu
Journal:  J Med Virol       Date:  2022-06-12       Impact factor: 2.327

2.  Monkeypox vaccination plans take shape amid questions.

Authors:  Kai Kupferschmidt
Journal:  Science       Date:  2022-06-09       Impact factor: 47.728

3.  Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.

Authors:  John P Thornhill; Sapha Barkati; Sharon Walmsley; Juergen Rockstroh; Andrea Antinori; Luke B Harrison; Romain Palich; Achyuta Nori; Iain Reeves; Maximillian S Habibi; Vanessa Apea; Christoph Boesecke; Linos Vandekerckhove; Michal Yakubovsky; Elena Sendagorta; Jose L Blanco; Eric Florence; Davide Moschese; Fernando M Maltez; Abraham Goorhuis; Valerie Pourcher; Pascal Migaud; Sebastian Noe; Claire Pintado; Fabrizio Maggi; Ann-Brit E Hansen; Christian Hoffmann; Jezer I Lezama; Cristina Mussini; AnnaMaria Cattelan; Keletso Makofane; Darrell Tan; Silvia Nozza; Johannes Nemeth; Marina B Klein; Chloe M Orkin
Journal:  N Engl J Med       Date:  2022-07-21       Impact factor: 176.079

4.  Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022.

Authors:  Fuminari Miura; Catharina Else van Ewijk; Jantien A Backer; Maria Xiridou; Eelco Franz; Eline Op de Coul; Diederik Brandwagt; Brigitte van Cleef; Gini van Rijckevorsel; Corien Swaan; Susan van den Hof; Jacco Wallinga
Journal:  Euro Surveill       Date:  2022-06

5.  Quality of Sex Life and Perceived Sexual Pleasure of PrEP Users in the Netherlands.

Authors:  Mart Van Dijk; John B F De Wit; Thomas E Guadamuz; Joel E Martinez; Kai J Jonas
Journal:  J Sex Res       Date:  2021-06-15

6.  The changing epidemiology of human monkeypox-A potential threat? A systematic review.

Authors:  Eveline M Bunge; Bernard Hoet; Liddy Chen; Florian Lienert; Heinz Weidenthaler; Lorraine R Baer; Robert Steffen
Journal:  PLoS Negl Trop Dis       Date:  2022-02-11

7.  When a Neglected Tropical Disease Goes Global: Knowledge, Attitudes and Practices of Italian Physicians towards Monkeypox, Preliminary Results.

Authors:  Matteo Riccò; Pietro Ferraro; Vincenzo Camisa; Elia Satta; Alessandro Zaniboni; Silvia Ranzieri; Antonio Baldassarre; Salvatore Zaffina; Federico Marchesi
Journal:  Trop Med Infect Dis       Date:  2022-07-14

8.  Threatening communication: a critical re-analysis and a revised meta-analytic test of fear appeal theory.

Authors:  Gjalt-Jorn Ygram Peters; Robert A C Ruiter; Gerjo Kok
Journal:  Health Psychol Rev       Date:  2013-05-28
  8 in total
  2 in total

Review 1.  Atypical and Unique Transmission of Monkeypox Virus during the 2022 Outbreak: An Overview of the Current State of Knowledge.

Authors:  Jade C Riopelle; Vincent J Munster; Julia R Port
Journal:  Viruses       Date:  2022-09-11       Impact factor: 5.818

2.  Re: 'Clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection' by Mailhe et al.

Authors:  Yousra Kherabi; Liem Binh Luong Nguyen; Frédéric Batteux; Odile Launay
Journal:  Clin Microbiol Infect       Date:  2022-10-12       Impact factor: 13.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.